Biotech Deals Tracker

Oncology and macrophage deals: antibody modality, preclinical and Phase 1 focus. Five-year view.

Year	Deal partners	Asset / target	Modality	Deal type	Deal value	Stage at deal	Category

Data compiled from prior research plus a verified five-year web sweep; each deal links to a primary source. No figures invented. Dropdown filters use streamlined groups; the table shows the detailed values. Last updated: 7 July 2026.

Compiled by Ojas Immune, a biotechnology company harnessing macrophages for health, healing and regeneration.